Ebola: Liberia To Receive Sample Doses Of Experimental Drug, ZMapp To Treat Doctors

The Liberian government has revealed that sample doses of the experimental drug ZMapp to help combat the Ebola virus will be sent to the country to treat doctors infected with the disease.

The request was approved by the The White House as well as the United States Food and Drug Administration. The delivery of the ZMapp to Liberia follows a request made on Friday from Liberian President Ellen Johnson Sirleaf to President Barack Obama. It will be taken to Liberia by a U.S. government representative this week